$1.23
At close: Jun 23 EDT
$1.25
0.021.63%
Pre-Market: 4:51 PM EDT
Comments
Loading...
CASI Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CASI | Benzinga
CASI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 15
EPS Estimate
$-0.470
Quarterly Revenue Estimate
$6.28M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$31.37M
Analyze the earnings history of CASI Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals | -$0.52 | -$0.47 | — | — | $3.98M | $6.28M | — | — | 08/15/2025 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.71 | -$0.60 | -$0.69 | -15.00% | $3.41M | $6.10M | $6.24M | 2.30% | 05/16/2025 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.45 | $0.00 | -$0.79 | -100.00% | $6.87M | $7.39M | $13.36M | 80.73% | 03/31/2025 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.35 | -$0.62 | -$0.55 | 11.29% | $8.84M | $4.56M | $7.79M | 70.90% | 11/15/2024 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.77 | -$0.63 | -$0.52 | 17.46% | $9.82M | $4.43M | $3.98M | -10.18% | 08/16/2024 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.45 | -$0.05 | -$0.71 | -1320.00% | $8.35M | $12.00M | $3.41M | -71.59% | 05/14/2024 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.44 | -$0.24 | -$0.45 | -87.50% | $15.26M | $9.41M | $6.87M | -26.95% | 03/28/2024 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.38 | -$0.56 | -$0.35 | 37.50% | $10.21M | $10.40M | $8.84M | -15.02% | 11/14/2023 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.56 | -$0.50 | -$0.77 | -54.00% | $8.57M | $10.09M | $9.82M | -2.68% | 08/11/2023 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.62 | -$0.64 | -$0.45 | 29.69% | $9.06M | $9.10M | $8.35M | -8.27% | 05/17/2023 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.40 | -$0.37 | -$1.44 | -289.19% | $9.16M | $10.79M | $15.26M | 41.42% | 04/26/2023 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.73 | -$0.46 | -$0.38 | 17.39% | $8.11M | $9.90M | $10.21M | 3.16% | 11/14/2022 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.40 | -$0.64 | -$0.56 | 12.50% | $7.16M | $7.87M | $8.57M | 8.93% | 08/12/2022 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.10 | -$0.90 | -$0.60 | 33.33% | $5.74M | $9.23M | $9.06M | -1.82% | 05/12/2022 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.20 | -$0.60 | -$0.40 | 33.33% | $4.82M | $9.07M | $9.16M | 0.97% | 03/28/2022 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.40 | -$0.50 | -$0.70 | -40.00% | $4.24M | $7.54M | $8.11M | 7.59% | 11/12/2021 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.90 | -$0.70 | -$0.50 | 28.57% | $2.67M | $6.02M | $7.16M | 18.97% | 08/12/2021 | Get Alert |
| CASI | CASI Pharmaceuticals | -$0.90 | -$0.60 | -$1.10 | -83.33% | $3.41M | $5.05M | $5.74M | 13.58% | 05/13/2021 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.30 | -$0.70 | -$1.20 | -71.43% | $1.34M | $4.45M | $4.82M | 8.36% | 03/30/2021 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.00 | -$0.50 | -$1.40 | -180.00% | $2.79M | $3.44M | $4.24M | 23.31% | 11/09/2020 | Get Alert |
| CASI | CASI Pharmaceuticals | -$1.60 | -$0.80 | -$0.90 | -12.50% | $0.00 | $3.75M | $2.67M | -28.77% | 08/10/2020 | Get Alert |
CASI Pharmaceuticals (CASI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-16 | $-0.69 | $-0.60 | -15.0 % |
| Q4 | 2025-03-31 | $-0.79 | $0 | -100.0 % |
| Q3 | 2024-11-15 | $-0.55 | $-0.62 | 11.3 % |
| Q2 | 2024-08-16 | $-0.52 | $-0.63 | 17.5 % |
CASI Pharmaceuticals (CASI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-16 | $6.24M | $6.10M | 2.30 % |
| Q4 | 2025-03-31 | $13.36M | $7.39M | 80.7 % |
| Q3 | 2024-11-15 | $7.79M | $4.56M | 70.9 % |
| Q2 | 2024-08-16 | $3.98M | $4.43M | -10.2 % |
FAQ
When is CASI Pharmaceuticals (NASDAQ:CASI) reporting earnings?
CASI Pharmaceuticals (CASI) is scheduled to report earnings on August 15, 2025. The last reported earnings were for reported on May 16, 2025 for Q1.
What were the latest earnings per share (EPS) for CASI Pharmaceuticals (NASDAQ:CASI)?
The Actual EPS was $-0.69, which missed the estimate of $-0.60.
What were CASI Pharmaceuticals’s (NASDAQ:CASI) revenues?
The Actual Revenue was $6.2M, which beat the estimate of $6.1M.
Browse earnings estimates, EPS, and revenue on all stocks.
